Morton's Neuroma Clinical Trial
Official title:
A Multicenter, Prospective, Randomized and Subject Blinded Comparative Study of AxoGuard® Nerve Cap and Neurectomy for the Treatment of Symptomatic Neuroma and Prevention of Recurrent End-Neuroma Pain
Comparing safety, pain, user experience, healthcare economic costs, work productivity, impairment and quality of life outcomes between Axoguard® Nerve Cap and neurectomy in the treatment of symptomatic neuromas in the foot. Study consists of a 15 subject pilot phase with Axoguard® Nerve Cap implants followed for 3 months and then a comparative study of 86 subjects randomized between the treatment groups followed for 12 months.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT00284583 -
Comparison of Alcohol and Steroid Injection for Treating Morton's Neuroma
|
N/A | |
| Recruiting |
NCT05695339 -
Resiniferatoxin for the Management of Refractory Morton s Neuroma Pain
|
Phase 1 | |
| Completed |
NCT02550756 -
Study to Evaluate the Safety and Tolerability of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)
|
Phase 1 | |
| Completed |
NCT01298310 -
A Study to Characterize the Phenotype in Patients With Morton's Neuroma and to Explore the Effect of Local Administration of Xylocaine (Lidocaine)
|
Phase 0 | |
| Completed |
NCT02678793 -
A Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)
|
Phase 2 | |
| Active, not recruiting |
NCT05604144 -
Cryoanalgesia for the Treatment of Pain in Subjects With Morton's Neuroma
|
N/A |